4//SEC Filing
Doyle Mittie 4
Accession 0001209191-22-022056
CIK 0001645569other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:27 PM ET
Size
5.6 KB
Accession
0001209191-22-022056
Insider Transaction Report
Form 4
Doyle Mittie
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-31+42,500→ 42,500 totalExercise: $19.13Exp: 2032-03-31→ Common Stock (42,500 underlying)
Footnotes (1)
- [F1]The option vests as to 1/36th of the total shares on each monthly anniversary of March 31, 2022, subject to the Reporting Holder's continued service to the Registrant.
Documents
Issuer
DICE Therapeutics, Inc.
CIK 0001645569
Entity typeother
Related Parties
1- filerCIK 0001918845
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:27 PM ET
- Size
- 5.6 KB